IL2, interleukin 2, 3558

N. diseases: 950; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0022665
Disease: Kidney Neoplasm
Kidney Neoplasm
0.310 Therapeutic disease CTD_human High-dose intensity pulse interleukin-2 with famotidine in metastatic kidney cancer. 19409039 2009
CUI: C0022665
Disease: Kidney Neoplasm
Kidney Neoplasm
0.310 Therapeutic disease CTD_human EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: a case report. 18625569 2009
CUI: C0022665
Disease: Kidney Neoplasm
Kidney Neoplasm
0.310 Therapeutic disease CTD_human Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer. 18298334 2008
CUI: C0022665
Disease: Kidney Neoplasm
Kidney Neoplasm
0.310 Biomarker disease BEFREE We previously showed that Vdelta2 T cells infiltrate renal tumors and can be expanded as potent cytotoxic effectors from peripheral blood mononuclear cells of most renal cell carcinoma (RCC) patients, using a structural analog of nonconventional T-cell receptor gamma9delta2 ligand, bromohydrin pyrophosphate, and interleukin-2 (IL-2). 18317356 2008
CUI: C0022665
Disease: Kidney Neoplasm
Kidney Neoplasm
0.310 Therapeutic disease CTD_human Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2. 17105418 2006